To further analyse the associations between genetic variants in ESR1, ESR2, and CYP2D6 on BMD, we initiated a prospective study to evaluate the changes in BMD in both pre- and postmenopausal women who were recommended tamoxifen either as adjuvant therapy for newly diagnosed breast cancer or for chemoprevention. Here, ESR1 is linked to breast cancer.